Diseases, Conditions, Syndromes

WHO halts hydroxychloroquine trials on COVID-19 patients

The World Health Organization decided Wednesday to halt trials of hydroxychloroquine as a potential treatment for hospitalised COVID-19 patients, finding it did not reduce the mortality rate.

Medications

Treatments for coronavirus: Repurposing existing drugs

Why develop new drugs to combat the replication of the coronavirus if existing approved substances could do the same thing? Repurposing drugs in this fashion could offer a faster remedy against pathogens that have as yet ...

Medications

Potential new heartburn drug studied at VUMC

An investigational drug that binds bile acids in the stomach can reduce the severity of heartburn symptoms in patients with treatment-resistant gastroesophageal reflux disease (GERD) when combined with a proton pump inhibitor ...

Medications

Neurosteroid antidepressants on horizon

More than 14 million Americans suffer from clinical depression, yet one in three doesn't experience relief from approved antidepressant drugs. A new treatment approach involving drugs called neurosteroids is on the horizon, ...

Diseases, Conditions, Syndromes

Sickle cell drug showing promise in clinical trial

An investigational drug for the treatment of sickle cell disease is showing early promise in clinical trials for impacting biomarkers of the disease in patients, reported UConn School of Medicine researchers at the European ...

page 3 from 12